On the one hand, a study showed that gene STXBP5 inhibits endothelial exocytosis and promotes platelet secretion, and the variation within STXBP5 is a genetic risk for venous thromboembolic disease [48]. This evidence concerns the gene STXBP5 and venous thromboembolism.